Lords Mark Inds.

Lord's Mark Industries set FY2027 consolidated revenue guidance of at least ₹1,550 crore and PAT of at least ₹178 crore, implying growth of more than 20% and 50%, respectively, over FY2026. It proposed demerging its renewable energy and LED division into Lords Shakti Power, retaining a 60% stake and distributing shares in the new entity to existing shareholders. It planned an exclusive India agreement for CAR-T therapy and treatment capability at five centres, with the first two targeted for Mumbai and Bengaluru by March 2027. It had established a UK subsidiary and was in the process of establishing a Swiss subsidiary to operate pathology laboratories supplied from its Indian manufacturing base, with an NHS approval application submitted for the UK operation. A new healthcare-delivery subsidiary was to begin with two approximately 70-bed oncology hospitals at Vapi and Solapur, supported by a proposed ₹200 crore debt raise, alongside a planned network of 50 dialysis centres. OneDNA patient trials were complete and the platform had received ICMR approval; the Biomescan platform had received its manufacturing licence on 10 August. Healthcare and diagnostics accounted for roughly 75% of FY26 revenue, while borrowings stood at ₹274 crore.

Powered by Tijori

Lord's Mark Industries received a manufacturing licence under India's Medical Devices Rules, 2017 for its Biomescan Analytics Platform, describing it as the country's first and only such licence for an IVD software product. The Software as a Medical Device combines whole-metagenome sequencing with a bioinformatics pipeline to produce gut-microbiome profiles, diversity scores, enterotype classifications and personalised dietary recommendations. The platform was licensed as a wellness and health-information tool for preventive healthcare and early health-risk assessment. Healthcare contributed about 75% of FY26 revenue, and the company commissioned a 14,000-square-foot IVD facility at Vasai in June.

Powered by Tijori

Aug 10 (Reuters) - Lord's Mark Industries Ltd LORS.BO:

• LORD'S MARK INDUSTRIES - RECEIVES MANUFACTURING LICENCE FOR BIOMESCAN ANALYTICS PLATFORM

Source text: ID:nBSE1sb1sJ

Further company coverage: LORS.BO

(([email protected];))

Lord's Mark Industries' board approved in principle a two-step scheme to meet the 25% minimum public shareholding requirement, combining an offer for sale by the promoter group with a rights issue subscribed exclusively by public shareholders. It also constituted a dedicated MPS Committee and appointed Nuvama Wealth Management as advisor for the restructuring and related corporate actions. The company had approved a preferential allotment at ₹195 a share in late July. Its standalone FY26 fourth-quarter revenue was ₹442 crore and profit after tax was ₹41 crore.

Powered by Tijori

July 20 (Reuters) - Lord's Mark Industries Ltd LORS.BO:

• LORD'S MARK INDUSTRIES LTD - ACHIEVES L1 STATUS FOR CONTRACT FROM CHHATTISGARH STATE RENEWABLE ENERGY DEVELOPMENT AGENCY

Source text: ID:nnAZN4T8RSX

Further company coverage: LORS.BO

(([email protected];))

Lord's Mark Industries Limited has commissioned a new 14,000-square-foot in-vitro diagnostics manufacturing unit at Vasai East in Maharashtra, two months ahead of its original August 2026 schedule. The facility expands the company's total operational manufacturing area from 20,000 square feet to 34,000 square feet. The plant will produce a portfolio of 56 ELISA test kits and a new range of rapid diagnostic test kits. The research and development wing has been dedicated to the memory of the late Ratan Tata and will focus on molecular biology and genetic science. The company also disclosed plans for a third facility, also at Vasai, dedicated to early cancer detection research and named after the late Dr. A.P.J. Abdul Kalam, with operations expected from January 2029, as well as a long-term vision to build one of the world's largest AI-enabled medical device manufacturing plants in India.

Powered by Tijori

June 23 (Reuters) - Lord's Mark Industries Ltd LORS.BO:

• LORD'S MARK INDUSTRIES - SETS UP 14,000 SQ FT IVD MANUFACTURING FACILITY AT VASAI, MAHARASHTRA

Source text: ID:nBSE2fl7LR

Further company coverage: LORS.BO

(([email protected];))

Lords Mark Industries resolved a legal dispute with Bennett Coleman and Co. Ltd after the Delhi High Court dismissed a petition seeking interim relief over the conversion of five warrants. The company issued a communication confirming BCCL's entitlement to 10,28,483 equity shares at a conversion price of ₹158 per share under a share cum warrant subscription agreement dated August 1, 2023. The petition, filed under Section 9 of the Arbitration and Conciliation Act, was withdrawn after Lords Mark acknowledged the obligation and committed to issuing the shares within three days of the court's order. The development removes a key uncertainty ahead of the company's planned listing and commenced trading of its equity shares.

Powered by Tijori

March 10 (Reuters) - Lord's Mark Industries Ltd LORS.BO:

• LORD'S MARK INDUSTRIES - ENTERS TECHNOLOGY TRANSFER AGREEMENT WITH C-MET FOR BREAST CANCER DETECTION DEVICE

Source text: ID:nBSEb7XLV2

Further company coverage: LORS.BO

(([email protected];))

Feb 16 (Reuters) - Lord's Mark Industries Ltd LORS.BO:

• LORD'S MARK INDUSTRIES LTD - SIGNING OF MOU FOR GREEN HYDROGEN PROJECTS

Source text: ID:nBSE8FBKpj

Further company coverage: LORS.BO

(([email protected];))

Jan 13 (Reuters) - Lord's Mark Industries Ltd LORS.BO:

• SECURES NHAI MANDATE FOR SOLAR HIGHWAY LIGHTING

Source text: ID:nBSEbJFPhS

Further company coverage: LORS.BO

(([email protected];))

Jan 6 (Reuters) - Lord's Mark Industries Ltd LORS.BO:

• APPROVAL TO RAISE 2 BILLION RUPEES VIA RIGHTS ISSUE

Source text: ID:nBSE24KQmf

Further company coverage: LORS.BO

(([email protected];))

March 4 (Reuters) - Kratos Energy & Infrastructure Ltd KRAT.BO:

• SEBI RELEASES ATTACHMENT OF KRATOS ENERGY BANK ACCOUNTS

Source text: ID:nBSEbG1R9G

Further company coverage: KRAT.BO

(([email protected];;))